Pharmaconex

Unveiling Africa’s Pharma Growth Opportunities

Pharmaconex is North Africa’s pharmaceutical hub, connecting the entire supply chain in Egypt, the largest producer of the pharmaceutical market in the MENA region. It offers a 365 Marketplace for our communities to interact, network, and build knowledge around the latest industry trends through physical and online opportunities.

Pharmaconex is held in association with CPhI, The world's largest pharmaceutical exhibition with over 30 years of experience. 

Exhibition Sectors

Uniting the global pharmaceutical industry through EIGHT dedicated product sectors with a combined mega show

Key highlights from the opening of the 8th edition - 2021


INFORMA ALLSECURE

Informa AllSecure is our approach to enhanced health & safety standards at our events following COVID-19. 

Informa has collaborated with association partners including UFI, AEO and SISO, peers including Reed Exhibitions and Clarion, venues, suppliers, contractors and health, government and local authorities to develop industry-wide All Secure standards that raise the bar on safe, hygienic, productive and high-quality organised event experiences.

Informa AllSecure is how these standards are being adopted in our business. It means that when exhibitors, speakers, sponsors and attendees come to our events, they can connect, learn, know more and do more business, effectively, safely and with confidence.


Mega trends in the Pharmaceutical Industry-Global & North Africa

Frost and Sullivan report  "MEGA TRENDS IN THE PHARMACEUTICAL INDUSTRY"

The Global Pharmaceutical industry’ is in a state of flux, working towards win-win transformations across all value chains from manufacturers, providers, and patients. The global pharmaceutical market was estimated to be around USD 1.2 trillion in 2018 and is expected to reach about USD 1.9 trillion by 2025, growing at a CAGR of about 6.2%. Growth in the market is majorly attributed to the launch of novel therapies, expansion of existing therapies, market expansion in emerging countries and growth of the aging population in the developed countries